[Factitious Disease Caused by Secret Administration of the Oral Anticoagulant Phenprocoumon: Study of 16 Personal Cases]
Overview
Authors
Affiliations
Background: It is frequently difficult to disclose covert ingestion of cumarins being the underlying cause of a bleeding disorder.
Patients And Methods: We report on 16 cases (15 patients) of phenprocoumon (Marcumar) abuse. All patients (9 females, 6 males) were admitted to the hospital because of bleeding and/or prolonged thromboplastin times. Analysis of phenprocoumon in the blood was performed by HPLC.
Results And Conclusions: The clinical presentation of the bleeding was highly variable. Thromboplastin times ranged from < 5 to 58%. With the exception of two patients with hepatic dysfunctions factor V activity was normal. All but one patient denied the ingestion of Marcumar. One patient died from hemorrhage. Two types of patients emerge from our series: Type I is the young nurse (8 cases), type II the usually male patient formerly treated with phenprocoumon (5 cases). Type I patients had long medical histories and showed autoaggressive behavior including the artificial manipulation of disorders other than hemorrhage. Thromboplastin times however were within or close to the therapeutic range (10 to 25%). Type II patients did not simulate other diseases in addition to hemorrhage. Thromboplastin times were longer than in type I patients. In all instances discrimination between non suicidal and suicidal behaviour was difficult. Psychiatric consultance is indicated.
A guide to acquired vitamin K coagulophathy diagnosis and treatment: the Russian perspective.
Wojciechowski V, Calina D, Tsarouhas K, Pivnik A, Sergievich A, Kodintsev V Daru. 2017; 25(1):10.
PMID: 28416008 PMC: 5393004. DOI: 10.1186/s40199-017-0175-z.
[Successful therapy of phenprocoumon poisoning with plasmapheresis].
Glaser V, Seifert R Med Klin (Munich). 1998; 93(3):174-6.
PMID: 9564165 DOI: 10.1007/BF03044835.